Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction of Candesartan and Amlodipine in Healthy Volunteers
NCT02064621Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of candesartan and amlodipine in hypertension (HTN) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Curve at Steady State over Dosing Interval at Day 9 and Maximum Plasma Concentration at Steady State at Day 9. Started Jun 2014; status: completed.
02
Drugs
candesartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02064621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064621.